Skip to main content
Sign In

You have reached the Web site for the Department of Pathology at the University of Colorado Denver.

Pathology Banner Image

Matthew Sikora, PhD

Assistant Professor

Education and Traning:​
  • Postdoctoral Research, Women’s Cancer Research Center – University of Pittsburgh Cancer Institute, Pittsburgh, PA (2011-2016)
  • Ph.D., Pharmacology, 2011 – University of Michigan, Ann Arbor, MI (2006-2011)
  • B.S., Genetics and Molecular Biology – University of Michigan, Ann Arbor, MI (2002-2006)

Research Interests:

  • Mechanisms of estrogen receptor (ER) signaling in breast cancer, with a focus on invasive lobular carcinoma (ILC)

  • Mechanisms of resistance to endocrine therapies (ie anti-estrogen drugs)

  • Hormone receptor signaling and transcriptomics during endocrine therapy and the development of resistance to endocrine therapy

  • Development of new therapeutic strategies for breast cancer

Selected Publications: 

For full listings, see or search ‘Sikora MJ’ on Pubmed; further discussion and explanation of our work can be found at

  • Sikora, M.J., et al. WNT4 mediates estrogen receptor signaling and endocrine resistance in invasive lobular carcinoma cells. In revision, Breast Cancer Research.
  • Sikora, M.J., et al. Endocrine response phenotypes are altered by charcoal-stripped serum variability. Endocrinology. 2016 Jul 26:en20161297. [Epub ahead of print] PubMed PMID: 27459541.
  • Sikora, M.J., et al. Invasive lobular carcinoma cell lines are characterized by unique estrogen-mediated gene expression patterns and altered tamoxifen response. Cancer Res. 2014;74:1463–74. PMID: 24425047. PMCID: PMC3955299.
  • Sikora, M.J., et al. Invasive lobular carcinoma of the breast: patient response to systemic endocrine therapy and hormone response in model systems. Steroids. 2013 Jun;78(6):568-75. PMID: 23178159.
  • Sikora, M.J., et al. Mechanisms of estrogen-independent breast cancer growth driven by low estrogen concentrations are unique versus complete estrogen deprivation. Breast Cancer Res Treat. 2012;134:1027–39. PMID: 22456984. PMCID: PMC3951731.
  • Sikora, M.J., et al. The Androgen Metabolite 5α-androstane-3β,17β-diol (3βAdiol) Induces Breast Cancer Growth via Estrogen Receptor: Implications for Aromatase Therapy.  Breast Cancer Res Treat. 2009 May;115(2):289-96. PMID: 18521740. PMCID: PMC2728015.



Phone: 303-724-4301

Twitter: @mjsikora

Office location: Univ. of Colorado Denver | Anschutz Medical Campus

Research Center 1 South, Room 5117